spacer
home > epc > winter 2017 > data-driven
PUBLICATIONS
European Pharmaceutical Contractor

Data-Driven

Advancements in science and technology – coupled with rising R&D activities – and the increasing automation of laboratories and stringency of regulatory requirements are all resulting in the generation of a large volume of scientific data from R&D, manufacturing and quality assurance processes. As a consequence, there is a growing need for life sciences firms to efficiently manage large volumes of information; enhance connectivity and productivity; comply with strict regulations; survive swelling commercial pressures; and improve quality and operational efficacy. In short, the demand for effective data management solutions such as lab informatics has increased. This is particularly pronounced in labs engaged in collecting, analysing and mining experimental information in highly automated environments.

The evolution of informatics has culminated in the development of various systems with diverse capabilities, such as:
  • Lab information management systems (LIMS)
  • Electronic data capture (EDC)
  • Clinical data management systems (CDMS)
  • Electronic lab notebooks (ELN)
  • Lab execution systems (LES)
  • Scientific data management systems (SDMS)
  • Chromatography data systems (CDS)
  • Enterprise content management (ECM)
These solutions include a number of software platforms that help automate and accelerate R&D processes; assist in tracking samples; streamline information exchange with equipment; track lab procedures; reduce turnaround time; and ensure compliance with Good Laboratory Practice standards and FDA regulations.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Madhuri Tekchandani is Assistant Manager of Healthcare at MarketsandMarkets and has five years of experience in market research and consulting. Having worked on several syndicated reports and consulting projects, her expertise includes mapping market dynamics and understanding their business impact. Madhuri completed a Master’s degree in Business Administration with specialisation in Finance, and has a Bachelor’s degree in Biomedical Engineering from the University of Mumbai, India.

With strong technical and analytical knowledge, Saakshi Shrivastava is a Research Analyst of Healthcare at MarketsandMarkets. She provides business and market analysis solutions with detailed attention on forecasting, competitive intelligence and analysis. Saakshi holds a postgraduate diploma in Pharmaceutical Management with specialisation in Marketing and completed her graduation in Biotechnology.

spacer
Madhuri Tekchandani
spacer
spacer
spacer
Saakshi Shrivastava
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

BBI Solutions broadens antibody portfolio and strengthens reagent technical support capabilities with acquisition of Maine Biotechnology Services

BBI, a leading manufacturer of raw materials and finished test platforms, already provides human antigens, antibodies, serum and plasma products and clinical chemistry enzymes, for the in-vitro diagnostics market. Now with the acquisition of MBS they have strengthened their antibody offering, providing a comprehensive portfolio and custom services to deliver a total reagent solution for any immunoassay development.
More info >>

White Papers

Competitive Drive: The Challenges of a Globalised Packaging Industry

Aesica Pharmaceuticals

Packaging is becoming an increasingly competitive and lucrative industry globally. Jeremy Drummond PhD of Aesica Formulated Products looks at the challenges and opportunities this presents.
More info >>

 
Industry Events

5th Biennial Biosimilars & Biobetters Congress 2018

16-17 April 2018, Novotel London West Hotel, Hammersmith, London

Oxford Global are proud to present our highly anticipated 5thBiennial Biosimilars & Biobetters Congress, 16th – 17thApril 2018, London, UK. Over 450 proteins, peptides and biosimilars delegates representing leading biotech companies, global pharmaceutical organisations and internationally renowned academic institutions will enjoy over 20 presentations and case studies focusing on the key areas of the biosimilars industry including market access strategies, clinical development, commercialisation, manufacturing and bio-analytics
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement